The Ohio Board of Pharmacy has lifted ban on sale or distribution of hydroxychloroquine for COVID-19, the board announced this ban lift after facing opposition from Ohio Gov. Mike DeWine, the Dayton Daily News reported Thursday.
Daily News also reports that DeWine statement saying “I agree with the statement from Dr. Steven Hahn, Commissioner of the Food and Drug Administration, that the decision about prescribing hydroxychloroquine to treat COVID-19 should be between a doctor and a patient.”
“Therefore, I am asking the Ohio Board of Pharmacy to halt their new rule,” DeWine said. “The Board of Pharmacy and the State Medical Board of Ohio should revisit the issue, listen to the best medical science, and open the process up for comment and testimony from experts.”
Recall that approval for the use of Hydroxychloroquine was revoked by FDA in June 2020.
Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, told “Good Morning America” Tuesday, “The overwhelming, prevailing clinical trials that have looked at the efficacy of hydroxychloroquine have indicated that it is not effective in coronavirus disease.”